JP4136867B2 - ラネリック酸ストロンチウム及びその水和物の新規な工業的合成方法 - Google Patents

ラネリック酸ストロンチウム及びその水和物の新規な工業的合成方法 Download PDF

Info

Publication number
JP4136867B2
JP4136867B2 JP2003330440A JP2003330440A JP4136867B2 JP 4136867 B2 JP4136867 B2 JP 4136867B2 JP 2003330440 A JP2003330440 A JP 2003330440A JP 2003330440 A JP2003330440 A JP 2003330440A JP 4136867 B2 JP4136867 B2 JP 4136867B2
Authority
JP
Japan
Prior art keywords
formula
compound
mol
iii
synthesis method
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2003330440A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004149516A (ja
JP2004149516A5 (enExample
Inventor
ルシル・ヴェイス−リュド
ジャン−ピエール・ルクヴ
パスカル・ラングロア
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Servier SAS
Original Assignee
Laboratoires Servier SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Servier SAS filed Critical Laboratoires Servier SAS
Publication of JP2004149516A publication Critical patent/JP2004149516A/ja
Publication of JP2004149516A5 publication Critical patent/JP2004149516A5/ja
Application granted granted Critical
Publication of JP4136867B2 publication Critical patent/JP4136867B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Inorganic Insulating Materials (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP2003330440A 2002-09-24 2003-09-22 ラネリック酸ストロンチウム及びその水和物の新規な工業的合成方法 Expired - Fee Related JP4136867B2 (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0211763A FR2844795B1 (fr) 2002-09-24 2002-09-24 Nouveau procede de synthese industriel du ranelate de strontium et de ses hydrates

Publications (3)

Publication Number Publication Date
JP2004149516A JP2004149516A (ja) 2004-05-27
JP2004149516A5 JP2004149516A5 (enExample) 2007-09-20
JP4136867B2 true JP4136867B2 (ja) 2008-08-20

Family

ID=29415189

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003330440A Expired - Fee Related JP4136867B2 (ja) 2002-09-24 2003-09-22 ラネリック酸ストロンチウム及びその水和物の新規な工業的合成方法

Country Status (37)

Country Link
US (1) US7214805B2 (enExample)
EP (1) EP1403266B1 (enExample)
JP (1) JP4136867B2 (enExample)
KR (1) KR100551501B1 (enExample)
CN (1) CN1212321C (enExample)
AP (1) AP1910A (enExample)
AR (1) AR041355A1 (enExample)
AU (2) AU2003282179A1 (enExample)
BR (1) BR0304213A (enExample)
CA (1) CA2442878C (enExample)
CR (1) CR7764A (enExample)
CY (1) CY1115162T1 (enExample)
DK (1) DK1403266T3 (enExample)
EA (1) EA007489B1 (enExample)
EC (1) ECSP055741A (enExample)
ES (1) ES2478620T3 (enExample)
FR (1) FR2844795B1 (enExample)
GE (1) GEP20074215B (enExample)
HR (1) HRP20050359B1 (enExample)
IL (1) IL167316A (enExample)
IS (1) IS7807A (enExample)
MA (1) MA26102A1 (enExample)
ME (1) ME00455B (enExample)
MX (1) MXPA03008643A (enExample)
MY (1) MY134921A (enExample)
NO (1) NO328638B1 (enExample)
NZ (1) NZ528402A (enExample)
OA (1) OA12934A (enExample)
PL (1) PL214400B1 (enExample)
PT (1) PT1403266E (enExample)
RS (2) RS53509B1 (enExample)
SG (1) SG110071A1 (enExample)
SI (1) SI1403266T1 (enExample)
TN (1) TNSN05087A1 (enExample)
UA (1) UA79156C2 (enExample)
WO (1) WO2004029036A1 (enExample)
ZA (1) ZA200307409B (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004098618A2 (en) * 2003-05-07 2004-11-18 Osteologix A/S Strontium combinations for prophylaxis/treatment of cartilage and/or bone conditions
ES2275218T3 (es) * 2003-05-07 2007-06-01 Osteologix A/S Sales de estroncio hidrosolubles para el tratamiento de afecciones de cartilagos y/o huesos.
PL1732575T3 (pl) 2004-02-26 2011-05-31 Osteologix As Związki zawierające stron do stosowania w zapobieganiu lub leczeniu stanów nekrotycznych kości
JP4954867B2 (ja) * 2004-05-06 2012-06-20 オステオロジックス エイ/エス 有機金属塩類を製造するための高収率で迅速な合成法
CA2571449C (en) 2004-06-25 2015-12-08 John Nikolaj Hvarre Christensen Compositions comprising strontium and vitamin d and uses thereof
FR2875807B1 (fr) * 2004-09-30 2006-11-17 Servier Lab Forme cristalline alpha du ranelate de strontium, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
CN100538672C (zh) * 2005-04-18 2009-09-09 索尼株式会社 控制设备和方法
CN100391955C (zh) * 2005-04-30 2008-06-04 河北医科大学 一种雷尼酸锶中间体的合成方法
CA2619720A1 (en) * 2005-08-19 2007-02-22 Glenmark Pharmaceuticals Limited Process for the preparation of strontium ranelate
US20070292535A1 (en) * 2006-06-19 2007-12-20 Tabbiner Philip S Strontium compositions and methods of treating arthritic and or osteoporitic conditions
US20070292529A1 (en) * 2006-06-19 2007-12-20 Tabbiner Philip S Strontium compositions and methods of treating osteoporotic conditions
FR2921367B1 (fr) * 2007-09-26 2009-10-30 Servier Lab Nouveau procede de synthese du ranelate de strontium et de ses hydrates
US20120123131A1 (en) * 2008-08-22 2012-05-17 Koilpillai Joseph Prabahar Process for the preparation of strontium ranelate
HU228820B1 (en) 2010-01-14 2013-05-28 Richter Gedeon Nyrt Process for the preparation of distrontium ranelate
WO2011110597A1 (de) 2010-03-11 2011-09-15 Azad Pharmaceutical Ingredients Ag Verfahren zur herstellung von strontiumranelat
WO2011124992A1 (en) * 2010-03-24 2011-10-13 Actavis Group Ptc Ehf Substantially pure strontium ranelate
US9301945B2 (en) 2011-07-21 2016-04-05 Emory University Methods for treating inflammatory conditions and states, and cancers by antagonizing NF-κB activation
CN102321068B (zh) * 2011-08-01 2013-01-23 山东铂源药业有限公司 一种雷奈酸锶的制备方法
WO2013175270A1 (en) * 2012-05-25 2013-11-28 Fleming Laboratories Limited Improved process for the preparation of strontium ranelate hydrates and new polymorphic form of monohydrate
ES2505716T3 (es) 2013-01-21 2015-09-04 Galenicum Health S.L. Composiciones farmacéuticas que comprenden una sal de ácido
CN103319454B (zh) * 2013-06-14 2014-06-18 广东众生药业股份有限公司 一种高纯度雷尼酸四乙酯及其中间体的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2651497B1 (fr) * 1989-09-01 1991-10-25 Adir Nouveaux sels de metaux bivalents de l'acide n, n-di (carboxymethyl)amino-2 cyano-3 carboxymethyl-4 carboxy-5 thiophene, leur procede de preparation et les compositions pharmaceutiques les renfermant.
FR2749759B1 (fr) * 1996-06-17 1999-11-26 Adir Utilisation de sels de strontium pour l'obtention de compositions pharmaceutiques destinees au traitement de l'arthrose
FR2844797B1 (fr) * 2002-09-24 2004-10-22 Servier Lab Nouveau procede de synthese industriel des tetraesters de l'acide 5-[bis (carboxymethyl)]-3-carboxymethyl-4-cyano-2- thiophenecarboxylique, et application a la synthese des sels bivalents de l'acide ranelique et de leurs hydrates
FR2844796A1 (fr) * 2002-09-24 2004-03-26 Servier Lab Nouveau procede de synthese industrielle du diester methylique de l'acide 5-amino-3-carboxymethyl-4-cyano-2- thiophenecarboxylique, et application a la synthese des sels bivalents de l'acide ranelique et de leurs hydrates

Also Published As

Publication number Publication date
AU2003282179A1 (en) 2004-04-19
TNSN05087A1 (fr) 2007-05-14
DK1403266T3 (da) 2014-07-07
AU2003248281B2 (en) 2009-08-06
ZA200307409B (en) 2004-07-07
AP1910A (en) 2008-10-30
ME00455B (me) 2011-10-10
CA2442878C (fr) 2009-03-03
CN1212321C (zh) 2005-07-27
KR100551501B1 (ko) 2006-02-13
FR2844795A1 (fr) 2004-03-26
ECSP055741A (es) 2005-07-06
HRP20050359B1 (hr) 2014-09-26
CR7764A (es) 2005-10-06
AU2003248281A1 (en) 2004-04-08
HRP20050359A2 (en) 2005-06-30
NO20034235D0 (no) 2003-09-23
EP1403266B1 (fr) 2014-04-09
KR20040026625A (ko) 2004-03-31
NO20034235L (no) 2004-03-25
OA12934A (en) 2006-10-13
BR0304213A (pt) 2004-08-31
CY1115162T1 (el) 2016-12-14
PL214400B1 (pl) 2013-07-31
PL362365A1 (en) 2004-04-05
FR2844795B1 (fr) 2004-10-22
PT1403266E (pt) 2014-05-06
IL167316A (en) 2008-08-07
US7214805B2 (en) 2007-05-08
AR041355A1 (es) 2005-05-11
EP1403266A1 (fr) 2004-03-31
NZ528402A (en) 2004-07-30
NO328638B1 (no) 2010-04-12
WO2004029036A1 (fr) 2004-04-08
RS53509B1 (sr) 2015-02-27
CA2442878A1 (fr) 2004-03-24
GEP20074215B (en) 2007-10-10
RS20050240A (sr) 2007-06-04
SG110071A1 (en) 2005-04-28
IS7807A (is) 2005-04-19
MA26102A1 (fr) 2004-04-01
ES2478620T3 (es) 2014-07-22
SI1403266T1 (sl) 2014-06-30
CN1496986A (zh) 2004-05-19
JP2004149516A (ja) 2004-05-27
EA007489B1 (ru) 2006-10-27
MXPA03008643A (es) 2005-04-19
MY134921A (en) 2008-01-31
HK1065791A1 (en) 2005-03-04
EA200300925A1 (ru) 2004-04-29
US20040063972A1 (en) 2004-04-01
UA79156C2 (en) 2007-05-25
AP2005003256A0 (en) 2005-03-31

Similar Documents

Publication Publication Date Title
JP4136867B2 (ja) ラネリック酸ストロンチウム及びその水和物の新規な工業的合成方法
JP4136866B2 (ja) 5−〔ビス(カルボキシメチル)アミノ〕−3−カルボキシメチル−4−シアノ−2−チオフェンカルボン酸のテトラエステル類の新規な工業的合成方法、並びにラネリック酸の二価塩類及びそれらの水和物の合成への応用
JP5016575B2 (ja) ストロンチウムラネレートおよびその水和物の新規な合成法
JP4136865B2 (ja) 5−アミノ−3−カルボキシメチル−4−シアノ−2−チオフェンカルボン酸のメチルジエステルの新規な工業的合成方法、並びにラネリック酸の二価塩類及びそれらの水和物の合成への応用
WO2023051768A1 (zh) (s)-4-氯-2-氨基丁酸盐酸盐及(s)-4-氯-2-氨基丁酸酯的制备方法
JP4408578B2 (ja) 3−(1−ヒドロキシ−ペンチリデン)−5−ニトロ−3h−ベンゾフラン−2−オン、その製造方法及びその用途
JPH08503939A (ja) α−アリール‐γ‐ブチロラクトンの製造方法
HK1065791B (en) New process for the industrial synthesis of strontium ranelate and its hydrates
JPS59122465A (ja) O−置換−5−ノルボルネン−2,3−ジカルボン酸ヒドロキシイミドの製造方法
JPH02304054A (ja) 新規なアニリド誘導体およびその製造方法
HK1096661B (en) An intermediate for the industrial synthesis of substituted thiophenecarboxylate

Legal Events

Date Code Title Description
A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20070802

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20070807

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20070809

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20071106

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20080507

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20080603

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110613

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120613

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130613

Year of fee payment: 5

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130613

Year of fee payment: 5

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140613

Year of fee payment: 6

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees